Key Financial Inc’s Sarepta Therapeutics SRPT Stock Holding History

Key Financial Inc’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.9K	Buy	1,050 +1,000	+2,000%	+$18.9K	﹤0.01%	738
2026 Q1	$1.08K	Hold	50	–	–	﹤0.01%	1246
2025 Q4	$1.06K	Hold	50	–	–	﹤0.01%	1248
2025 Q3	$956	Hold	50	–	–	﹤0.01%	1276
2025 Q2	$846	Hold	50	–	–	﹤0.01%	1288
2025 Q1	$3.16K	Hold	50	–	–	﹤0.01%	1087
2024 Q4	$6.02K	Hold	50	–	–	﹤0.01%	934
2024 Q3	$6.18K	Hold	50	–	–	﹤0.01%	923
2024 Q2	$7.82K	Hold	50	–	–	﹤0.01%	838
2024 Q1	$6.41K	Hold	50	–	–	﹤0.01%	874
2023 Q4	$4.77K	Hold	50	–	–	﹤0.01%	947
2023 Q3	$6K	Hold	50	–	–	﹤0.01%	848
2023 Q2	$5.67K	Hold	50	–	–	﹤0.01%	888
2023 Q1	$6.82K	Hold	50	–	–	﹤0.01%	758
2022 Q4	$5.47K	Hold	50	–	–	﹤0.01%	775
2022 Q3	$5K	Hold	50	–	–	﹤0.01%	806
2022 Q2	$4K	Hold	50	–	–	﹤0.01%	855
2022 Q1	$4K	Hold	50	–	–	﹤0.01%	840
2021 Q4	$4K	Hold	50	–	–	﹤0.01%	755
2021 Q3	$5K	Buy	50 +8	+19%	+$616	﹤0.01%	712
2021 Q2	$3K	Hold	42	–	–	﹤0.01%	748
2021 Q1	$3K	Hold	42	–	–	﹤0.01%	662
2020 Q4	$7K	Buy	+42	New	+$6.22K	0.01%	512
2020 Q2	–	Sell	-42	Closed	-$4K	–	550
2020 Q1	$4K	Buy	+42	New	+$4.8K	﹤0.01%	536

Other funds holding SRPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Key Financial Inc's SRPT Position: Q2 2026 in Review

Key Financial Inc increased its Sarepta Therapeutics (SRPT) stake by 2,000% in Q2 2026, buying an estimated $18.9K and bringing the position to 1,050 shares worth $18.9K. The position accounts for ﹤0.01% of the portfolio, ranked #738.

Key Financial Inc first reported a position in SRPT in Q1 2020 and has held it in 24 quarters since. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

Key Financial Inc held 1,050 shares of Sarepta Therapeutics worth $18.9K as of Q2 2026.
Key Financial Inc bought 1,000 Sarepta Therapeutics shares in Q2 2026, an estimated $18.9K.
Sarepta Therapeutics made up ﹤0.01% of Key Financial Inc's portfolio in Q2 2026, its #738 holding.
Key Financial Inc first reported a position in Sarepta Therapeutics in Q1 2020 and has held it in 24 quarters since.
323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Key Financial Inc's 13F filing for Q2 2026, filed 24 Jul 2026.